Writing from the hospital, columnist Kylene Henderson shares her husband Donnie's experience with COVID-19 pneumonia as ...

Health Canada approves new therapy Jascayd (nerandomilast) for adults with IPF and PPF, offering an option to slow lung ...

I cannot tell you how many times I’ve said this to myself over the past few weeks. In my adult life, I have moved about 16 times, including four moves to the other side of the world. I have driven ...

Admilparant, an experimental oral therapy being developed by Bristol Myers Squibb, slowed lung function declines among people with idiopathic pulmonary fibrosis (IPF) in a Phase 3 clinical trial.

The past year has been particularly challenging for my husband, Donnie, as he navigates persistent muscle soreness and fatigue, along with his regular pulmonary fibrosis symptoms. Because autoimmune ...

Lower activity of a gene called ZNF331 may help identify obstructive sleep apnea (OSA), marked by repeated stops and starts in breathing during sleep, in people with idiopathic pulmonary fibrosis (IPF ...

I am two days into another trip around the sun. Can you believe it? I didn’t. I’m still not sure how I feel about it. On Sunday, Oct. 4, I turned 69. I was 59 when I was diagnosed with idiopathic ...

Computer-based analyses of CT scans can help to predict future disease progression and track response to treatment among people with progressive pulmonary fibrosis (PPF), according to a new analysis ...

What is Ofev for idiopathic pulmonary fibrosis? Ofev (nintedanib) is an approved oral therapy used to treat people with idiopathic pulmonary fibrosis (IPF) and related lung conditions. It is not a ...